
Putative securities suits by Schall and Glancy cover Nano-X investors from March 31, 2025 to April 17, 2026 and allege misleading statements on product demand, operational efficiency, cash burn and manufacturing alignment.
Investors who bought Nano-X Imaging Ltd. securities between March 31, 2025 and April 17, 2026 have until August 11, 2026 to seek appointment as lead plaintiff in a putative securities class action, according to law-firm announcements from The Schall Law Firm and Glancy Prongay Wolke & Rotter LLP. The complaint alleges Nano-X overstated product demand and operational efficiency while failing to disclose that production and manufacturing were poorly aligned with demand, driving higher operating expenses and cash burn and increasing the likelihood of restructuring and impairment charges. The suit follows Nano-X's April 20, 2026 disclosure of a $33.4 million net loss, including a $17.5 million impairment charge tied to long-lived assets after a restructuring initiative at its Korean chip manufacturing facility, as well as the planned departure of its Chief Financial Officer. Nano-X shares fell $0.69, or 24.4%, to close at $2.16 on April 20, 2026. The class has not yet been certified, and investors may remain absent class members or retain counsel of their choice.